McKinley Kate has filed 7 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 120000 shares of Rani Therapeutics Holdings, Inc. ($RANI) on August 01, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 1, 2025 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 33,509,827 | 9999.99% | 0.36% |
| May 23, 2025 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | Chief Business Officer | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 33,509,827 | 9999.99% | 0.97% |
| Dec. 13, 2024 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | Chief Business Officer | P | Class A Common Stock | 17960 | $1.67 | 17,960.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | Chief Business Officer | A | Stock Option (Right to Buy) | 323500 | $0.00 | 323,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | Chief Business Officer | D | Stock Option (Right to Buy) | 250000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | Chief Business Officer | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | McKinley Kate | CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |